"Estrogen Receptor alpha" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the ESTROGEN RECEPTORS that has marked affinity for ESTRADIOL. Its expression and function differs from, and in some ways opposes, ESTROGEN RECEPTOR BETA.
Descriptor ID |
D047628
|
MeSH Number(s) |
D12.776.826.750.350.174
|
Concept/Terms |
Estrogen Receptor alpha- Estrogen Receptor alpha
- Estradiol Receptor alpha
- Receptor alpha, Estradiol
- alpha, Estradiol Receptor
- Receptor alpha, Estrogen
- ERalpha
- Estrogen Receptors alpha
|
Below are MeSH descriptors whose meaning is more general than "Estrogen Receptor alpha".
Below are MeSH descriptors whose meaning is more specific than "Estrogen Receptor alpha".
This graph shows the total number of publications written about "Estrogen Receptor alpha" by people in this website by year, and whether "Estrogen Receptor alpha" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 2 | 2 |
2000 | 0 | 5 | 5 |
2001 | 0 | 8 | 8 |
2002 | 0 | 7 | 7 |
2003 | 0 | 12 | 12 |
2004 | 7 | 9 | 16 |
2005 | 12 | 7 | 19 |
2006 | 17 | 7 | 24 |
2007 | 12 | 3 | 15 |
2008 | 9 | 7 | 16 |
2009 | 19 | 6 | 25 |
2010 | 16 | 9 | 25 |
2011 | 10 | 11 | 21 |
2012 | 9 | 7 | 16 |
2013 | 7 | 13 | 20 |
2014 | 16 | 10 | 26 |
2015 | 11 | 13 | 24 |
2016 | 11 | 5 | 16 |
2017 | 9 | 3 | 12 |
2018 | 10 | 5 | 15 |
2019 | 8 | 4 | 12 |
2020 | 12 | 9 | 21 |
2021 | 5 | 5 | 10 |
2022 | 4 | 1 | 5 |
2023 | 1 | 7 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Estrogen Receptor alpha" by people in Profiles.
-
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer. Cancer Res. 2023 10 02; 83(19):3237-3251.
-
RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion-Positive Breast Cancer and Beyond. Cancer Res. 2023 10 02; 83(19):3159-3161.
-
Gene transcription regulation by ER at the single cell and allele level. Steroids. 2023 Dec; 200:109313.
-
TRIM28 modulates nuclear receptor signaling to regulate uterine function. Nat Commun. 2023 08 01; 14(1):4605.
-
Macrophage-to-endothelial cell crosstalk by the cholesterol metabolite 27HC promotes atherosclerosis in male mice. Nat Commun. 2023 07 25; 14(1):4101.
-
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial. JAMA Oncol. 2023 06 01; 9(6):815-824.
-
17?-estradiol promotes extracellular vesicle release and selective miRNA loading in ERa-positive breast cancer. Proc Natl Acad Sci U S A. 2023 06 06; 120(23):e2122053120.
-
Estrogen Receptor Signaling in the Immune System. Endocr Rev. 2023 01 12; 44(1):117-141.
-
14-3-3t drives estrogen receptor loss via ERa36 induction and GATA3 inhibition in breast cancer. Proc Natl Acad Sci U S A. 2022 10 25; 119(43):e2209211119.
-
The Estrogen Receptor a Cistrome in Human Endometrium and Epithelial Organoids. Endocrinology. 2022 09 01; 163(9).